Table of Contents Table of Contents
Previous Page  372 / 1631 Next Page
Information
Show Menu
Previous Page 372 / 1631 Next Page
Page Background

Cliquez et modifiez le titre

• For advanced stage lymphomas, the indications for the use

of RT have been questioned and debated, and proper

randomized evidence is sparse.

• The modern concept of involved site radiation therapy

(ISRT) reduces late toxicity in advanced Hodgkin

lymphoma.

• RT to residual disease and/or initial bulk benefits some

patients, depending on the chemotherapy regimen used.

The more intensive the chemotherapy regimen, the fewer

patients benefit from RT

Conclusions

Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin

Lymphoma?

Specht L et al. Curr Treat Options Oncol. 2016 Jan;17(1):4.